BridgeBio Pharma Inc (FRA:2CL)
€ 60.3 +0.020 (+0.03%) Market Cap: 12.02 Bil Enterprise Value: 13.40 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 66/100

Q1 2026 BridgeBio Pharma Inc Earnings Call Transcript

May 07, 2026 / 08:30PM GMT
Release Date Price: €58.03 (+1.22%)
Operator

Good afternoon. I will be your conference operator today. All lines have been placed and muted to prevent any background noise. After the company's remarks, there will be a question-and-answer session. If you would like to ask a question, please press star followed by the number one on your telephone keypad. And if you would like to withdraw your questions, press star one again.

Thank you.

Before we begin, I would like to remind everyone that today's call may contain forward-looking statements within the meaning of the Federal Securities Law, including, but not limited to, statements about Fugefy's future operating and financial performance, business plans and prospects, and strategies. These statements are based on current expectations and assumptions that are subject to risks and uncertainties, which could cause actual results to differ materially from those expressed or implied in these forward-looking statements. For a discussion of this risk and uncertainties, please refer to the disclosure in today's earnings release and Bridge Bio's periodic reports and SEC filings.

All

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot